Abstract:In recent years targeted radionuclide therapy has become a topic of great interest as a growing number of cancers can potentially be treated with radionuclides like lutetium-177 and samarium-153. To facilitate this growth and meet the demand, preparation and purification of lutetium-177 is increasing in importance. In the most common production route, enriched ytterbium-176 targets are irradiated and the produced lutetium-177 is separated from the ytterbium target material. This challenging separation is commonly performed using ion exchange resins, a method limited in scalability as the chemical similarity between ytterbium and lutetium results in poor separation at higher concentrations. An alternative method to aid the separation of lutetium from ytterbium is the electrochemical reduction of ytterbium as a change in oxidation states changes chemical properties significantly. Ytterbium has an accessible divalent state, whereas lutetium has not. However, the very negative value of the Yb(III)/Yb(II) standard reduction potential (E 0 = -1.04 V vs. SHE) does pose some challenges as it becomes a necessity to work in non-aqueous solvents with a very low water content. Similar research has already been performed in our group, looking into the separation of samarium-153 from europium-154, reducing europium in nitrate media, followed by a separation over TEVA resin. In this study, we investigated the reduction of ytterbium in ethylene glycol, dimethyl sulfoxide, tetrahydrofuran and N,N-dimethyl formamide by cyclic voltammetry, linear sweep voltammetry and electronic impedance spectroscopy. The influence of multiple variables such as moisture content on the reduction kinetics and stability of Yb(II) was determined and a Koutecky-Levich analysis was performed. Our results demonstrate that the reduction of ytterbium in non-aqueous solvents is feasible but attempts to perform bulk electrolysis were not successful yet. Ethylene glycol, dimethyl sulfoxide and N,N-dimethyl formamide demonstrate favorable conditions and in each solvents clear reduction and oxidation peaks were observed. It was found that the solvents do affect the peak separation, reduction potential and sensitivity to passivation. Figure 1

Indirect Production of No Carrier Added (NCA) (177)Lu from Irradiation of Enriched (176)Yb: Options for Ytterbium/Lutetium Separation.

Effective lutetium/ytterbium separation for no-carrier added lutetium-177 production

Production of No-Carrier-added 186re Via Deuteron Induced Reactions on Isotopically Enriched 186W

Study on Production Method of the {sup 178m2}hf Isomer for Induced Gamma Emission

Alpha-hydroxyisobutyric acid-assisted solid-liquid chromatography for the separation of lutetium-177 from neutron-irradiated natural ytterbium

Production of Pd radionuclides from natural niobium and their purification simulating natNb(11B,xn)100,101Pd reaction: an indirect production route of 101mRh

Optimization of Deuteron Irradiation of 176Yb for Producing 177Lu of High Specific Activity Exceeding 3000 GBq/mg

Separation of no-carrier-added Bi and stable Bi from thallium

A versatile technique for radiochemical separation of medically useful no-carrier-added (nca) radioarsenic from irradiated germanium oxide targets

Production, separation and embedment of no-carrier added 93mMo in iron-doped calcium alginate beads from 7Li irradiated yttrium target

Synergistic aqueous biphasic separation of 90Nb and 89Zr from natY using green tea derived catechins

Simultaneous Production of 111In and 109Cd by Alpha Particle Irradiation of natAg Target and Synergistic Aqueous Biphasic Separation using Green Tea Polyphenols

Production of 225 Ac for medical application from 232 Th-metallic targets in Nb-shells irradiated with middle-energy protons

Analysis of lutetium-177 production at the WWR-K research reactor

Whole process establishment of carrier-free 177 Lu production: from small-scale production to pilot-scale production

Semi-Permanent Mass Production of Ac-225 for Cancer Therapy by the (3n,x) Reaction in Pressurized Water Reactor

Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target

The production and separation of 161Tb with high specific activity at the University of Utah

Electrochemical Reduction of Ytterbium in Non-Aqueous Solvents - Towards Production of Pure Medical Lutetium-177

Production and purification of molecular 225Ac at CERN-ISOLDE

Study of thulium-167 cyclotron production: a potential medically-relevant radionuclide